AI drugs researcher QuantumPharm makes market debut on long road to profit
The newly floated biotech can boast big-name backers and counts more than a dozen biopharma heavyweights among its customers, but it is still awash with red ink Key Takeaways: QuantumPharm’s…
Recent Articles
RELATED ARTICLES
-
InSilico seeks IPO boost to get AI drugs over the line
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
- Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
